Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Total Debt (2016 - 2024)

Prestige Consumer Healthcare has reported Total Debt over the past 14 years, most recently at $1.1 billion for Q1 2024.

  • For Q1 2024, Total Debt fell 16.35% year-over-year to $1.1 billion; the TTM value through Mar 2024 reached $1.1 billion, down 16.35%, while the annual FY2024 figure was $1.1 billion, 16.35% down from the prior year.
  • Total Debt for Q1 2024 was $1.1 billion at Prestige Consumer Healthcare, down from $1.3 billion in the prior quarter.
  • Over five years, Total Debt peaked at $1.7 billion in Q1 2020 and troughed at $6.0 million in Q3 2021.
  • A 5-year average of $1.3 billion and a median of $1.5 billion in 2021 define the central range for Total Debt.
  • Biggest five-year swings in Total Debt: plummeted 99.61% in 2021 and later decreased 0.2% in 2022.
  • Year by year, Total Debt stood at $1.5 billion in 2020, then tumbled by 99.61% to $6.0 million in 2021, then soared by 24510.97% to $1.5 billion in 2022, then decreased by 8.86% to $1.3 billion in 2023, then dropped by 16.35% to $1.1 billion in 2024.
  • Business Quant data shows Total Debt for PBH at $1.1 billion in Q1 2024, $1.3 billion in Q1 2023, and $1.5 billion in Q1 2022.